Vascular morphology and angiogenesis in glial tumors
References (62)
- et al.
Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells
Biochem Biophys Res Comm
(1991) - et al.
Angiogenesis
J Biol Chem
(1992) - et al.
Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor
FEBS letters
(1991) - et al.
Localization of acidic and basic fribroblast growth factor mRNA in human brain tumors
Jpn J Cancer Res
(1991) - et al.
Tumor Angiogenesis: A Quantitative Method for Histological Grading
J Natl Cancer Inst
(1972) The grading of carcinoma
Minn Med
(1925)Accumulation of genetic defects during astrocytoma progression
Cancer
(1992)- et al.
Grading of astrocytomas A simple and reproducible method
Cancer
(1988) - et al.
The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation
Cancer
(1958) - et al.
Sarcoma arising in glioblastoma of brain
American Journal of Pathology
(1955)
What is the evidence that tumor growth is angiogenesis dependent?
J Natl Cancer Inst
Tumor angiogenesis
Angiogenic factors
Science
Correlation of histopathological features and proliferative potential of gliomas
J Neurosurg
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67
Acta Neuropathol
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology
Mol Biol Cell
Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme
J Neuropath Exp Neuropathol
Smooth muscle cells can compromise the sarcomatous component of gliosarcomas
J Neuropath Exp Neuropathol
The angioarchitecture of the glioma
Brain
Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation
Proc Natl Acad Sci USA
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas
J Neurosurg
Clonal genomic alterations in glioma malignancy stages
Cancer Res
A simplified classification of the gliomas. Symposium on a new simplified concept of gliomas
Proc Staff Meet Mayo Clin
Histological Typing of Tumours of the Central Nervous System. World Health Organization, International Histological Classification of Tumours
The New WHO Classification of Brain Tumours
Brain Pathology
Immunohistochemical demonstration of DNA polymerase a in human brain-tumor cells
J Neurosurg
Amplification, enhanced expression and possible rearrangement of the EGF receptor in primary human brain tumors of glial origin
Nature
Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors
J Neurosurg
Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression
Cancer Res
Cited by (108)
Recent insights into nanoformulation delivery systems of flavonoids against glioblastoma
2024, Journal of Drug Delivery Science and TechnologyPrecise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers
2022, BiomaterialsCitation Excerpt :Glioma, particularly glioblastoma multiforme (GBM, grade IV, the most malignant [26]), is one of the most incurable tumors in primary central nervous system (CNS) due to the grave growth infiltration, extremely fast-spreading speed and grievously high recurrence rate [27–30]. Compared with other tumors, gliomas are characterized by hypoxia (< 10 mmHg) [31], which is imputed to the vascular folding caused by over-recruitment or proliferation of endothelial cells and lack of pericyte coating [32,33]. Consequently, HAPs possess a great therapy prospect in gliomas.
Targeting angiogenesis in gliomas: Potential role of phytochemicals
2022, Journal of Functional FoodsEvaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors
2022, Cancer GeneticsCitation Excerpt :Various preclinical studies have indicated that the growth ability of GBM critically depends on the generation of tumor-associated hyper-permeable blood vessels [1,4] that are characterized by a dense network with abnormally increased vessel diameter and thickness of basement membranes. This aberrant tumor vasculature is believed to enhance GBM growth and facilitate tumor metastasis that is contributing to treatment failure [5,6]. Therefore, antagonizing tumor vascular has been used as a strategy for brain tumor treatment, particularly for the GBM.
Functional magnetic resonance imaging
2022, Handbook of Neuro-Oncology NeuroimagingImaging of glioblastoma recurrence
2021, New Targeting in the Reversal of Resistant Glioblastomas